KWM
ONCY

Kingsview Wealth Management’s Oncolytics Biotech ONCY Stock Holding History

Kingsview Wealth Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.52K Hold
11,210
– – ﹤0.01% 1328
2025
Q4 		$9.8K Hold
11,210
– – ﹤0.01% 1230
2025
Q3 		$15.7K Hold
11,210
– – ﹤0.01% 1190
2025
Q2 		$8.66K Hold
11,210
– – ﹤0.01% 1162
2025
Q1 		$6.17K Sell
11,210
-790
-7% -$578 ﹤0.01% 1087
2024
Q4 		$11K Buy
12,000
+1,000
+9% +$1.04K ﹤0.01% 1098
2024
Q3 		$9.58K Hold
11,000
– – ﹤0.01% 1082
2024
Q2 		$10.9K Hold
11,000
– – ﹤0.01% 1032
2024
Q1 		$11.7K Hold
11,000
– – ﹤0.01% 1008
2023
Q4 		$14.8K Buy
+11,000
New +$17.2K ﹤0.01% 938

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Kingsview Wealth Management's ONCY Position: Q1 2026 in Review

Kingsview Wealth Management held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 11,210 shares worth $9.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

Kingsview Wealth Management first reported a position in ONCY in Q4 2023 and has held it in 10 quarters since. The position peaked at $15.7K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Kingsview Wealth Management held 11,210 shares of Oncolytics Biotech worth $9.52K as of Q1 2026.
  • Kingsview Wealth Management left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1328 holding.
  • Kingsview Wealth Management first reported a position in Oncolytics Biotech in Q4 2023 and has held it in 10 quarters since.
  • Kingsview Wealth Management's Oncolytics Biotech position peaked at $15.7K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.